Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 1998

View Archived Issues

Redox-oriented prophylactic therapy improves quality of life in cancer patients

Phase II study finds IL-2 fusion protein effective but toxic in patients with psoriasis

Phosphonic acids that block EAA receptors: new series from Novartis

Zeneca presents peptides for modifying autoimmune responses as in RA

Antitumor bis(acridinecarboxamide) and bis(phenazinecarboxamide) derivatives

European phase III testing under way with Cerus' platelet pathogen inactivation system

Boehringer Ingelheim reports preliminary findings of ECASS II trial

Troponin I inhibits retinal angiogenesis in animal studies

Micronetics, Praxis enter into reorganization agreement

Conjugated linoleic acid prevents, reverses atherosclerosis in animal models

FDA approves new dosing regimen for SB's amoxicillin

Synsorb announces commencement of U.S. phase II trials for CDAD Rx

First SELEX compound from NeXstar heads for clinical trials in ARMD

Allergan and Warner-Lambert collaborate on retinoid compounds for diabetes, metabolic disorders

Titan commences phase II trials of small-molecule anticancer agent

Efficacy of Demeter's Peptidyl MIM compounds demonstrated in animal models of prostate cancer

Combination of angiostatin and radiation results in significantly increased tumor growth inhibition

Long-term leflunomide prevents allergic sensitization in rats

Longer treatment with EMLA associated with increased pain relief during cleansing of leg ulcers

SB-209670 improves ischemia-reperfusion injury in canine lung allografts

First report of neural stem cells forming functioning dopamine-producing neurons in culture

AxyS elucidates 3-D structure of cathepsin S

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...